Investment
Features
FeesSafety
Academy
More
Pluang+

Tendinopathy market to grow through 2036 with new regenerative therapies and rising sports injuries.

Market News
08 Oct 2026
Globe News Wire
View Source
Neutral
Tendinopathy market to grow through 2036 with new regenerative therapies and rising sports injuries.

The global tendinopathy market is projected to expand through 2036, driven by increasing sports participation, occupational overuse, and aging populations. Current treatments focus on symptom relief, but emerging regenerative and mechanism-based therapies like Causeway Therapeutics' TenoMiR aim to improve tendon repair. Despite no approved disease-modifying therapies yet, the market offers significant opportunities due to persistent symptoms and high recurrence rates. Adoption of new treatments will depend on clinical success, regulatory approval, pricing, and reimbursement policies.

The global tendinopathy market insights highlight growth opportunities driven by regenerative therapies and unmet needs through 2036. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 23:11 WIB: out of 128 priced US health-sector stocks, 20 rose and 107 fell today. Notable movers include HIMS (Hims and Hers Health Inc) at USD 28.01 with a 1-day change of -5.18% and a typical hold time on Pluang of 21 days, with 0% sell and 100% buy order activity, SLS (SELLAS Life Sciences Group Inc.) at USD 10.79 down 4.60%, and NUVB (Nuvation Bio Inc.) at USD 4.65 down 4.32%.

More News

CIQ launches Fuzzball 4.3 for easy AI model deployment on existing GPU infrastructure

CIQ launches Fuzzball 4.3 for easy AI model deployment on existing GPU infrastructure

CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...

Market News
Bullish
56 minutes ago
Societe Generale reports 739 million shares and 821 million voting rights as of Sept 30, 2026.

Societe Generale reports 739 million shares and 821 million voting rights as of Sept 30, 2026.

As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....

Company Fundamentals
Neutral
56 minutes ago
Weyerhaeuser shares hit 52-week low amid mixed analyst price targets and dividend concerns.

Weyerhaeuser shares hit 52-week low amid mixed analyst price targets and dividend concerns.

Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...

Analyst Insights
Bearish
1 hour ago
Canadian Utilities to merge with Emera, RBC Capital keeps 'Sector Perform' rating

Canadian Utilities to merge with Emera, RBC Capital keeps 'Sector Perform' rating

Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...

Market News
Neutral
1 hour ago
Domino's Pizza Q3 earnings expected to rise slightly with focus on promo impact

Domino's Pizza Q3 earnings expected to rise slightly with focus on promo impact

Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App